Enduring Material

The Relative Benefits and Risks of Kratom Derived Products
View Activity Info
Enter Basic User Info
Create Account
View Content
Take Post Test
Done
View Activity Info
Continue to Enduring Material
 
 
MyMichigan Health

4000 Wellness Drive
Midland, MI 48670
General Information
Tuesday, June 9, 2026 - Saturday, June 9, 2029
70 minutes
MyMichigan Health
Virtual Conference Room
Michigan Medicine Opioid Overdose Prevention Education
MyMichigan Health
Objectives
  • Describe the three different types of kratom derived products (natural leaf, mitragynine extracts, and isolated synthetics (7-OH, mitragynine pseudoindoxyl, MGM-15/16).
  • Compare and contrast the pharmacologic similarities and differences between kratom derived products and traditional opioids.
  • Describe the clinical trial and descriptive (anecdotal) data on kratom derived products to determine the potential risks and benefits.
  • Describe a regulatory approach to reduce public health risk but maintain access to natural leaf kratom.
Presentations and Speakers
The Relative Benefits and Risks of Kratom Derived Products
  • C. Michael White, PharmD
Available Credits/Points
  • MyMichigan Health designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • MyMichigan Health designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
No planners or presenters have any relevant financial relationships with ACCME defined ineligible companies.
Speakers:
Charles Michael White, PharmD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Charles Michael White, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Kratom products are not FDA approved and neither are any of their alkaloids. The entire presentation will include off-label uses of a product but the relative strengths and limitations of the data will be described.

Planners and other Administrative Support:
Emily McKanna and Amanda L Newman have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Michigan OPEN. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Test Information
80 %
100 %
6/26/2026
Continue to Enduring Material